Search results for "Myc"

showing 10 items of 3773 documents

Mitomycin C bei oberflächlichen Hornhautablationen mit dem Excimer-Laser: Eigene Erfahrungen und Literaturübersicht

2005

Haze formation with loss of corneal transparency and surface irregularities and myopic regression are the major complications after corneal refractive surface surgery. The use of mitomycin C (MMC) with its antibiotic and antineoplastic properties is intended to inhibit wound healing mechanisms leading to subepithelial fibrosis. We report the use of MMC to achieve visual rehabilitation in the re-treatment of 3 eyes of 2 patients following refractive corneal surgery. According to the literature, the local use of MMC 0.02 % for 2 minutes is safe and enables one to treat and prevent stromal haze and myopic regression and allows a reduction of the postoperative topical pharmacotherapy. Results a…

medicine.medical_specialtygenetic structuresbusiness.industryMitomycin CVisual rehabilitationCorneal opacityeye diseasesCorneal transparencySurgeryOphthalmologyPharmacotherapyCorneal surgerySubepithelial fibrosisMedicinesense organsMajor complicationbusinessKlinische Monatsblätter für Augenheilkunde
researchProduct

Quality of life as a therapeutic objective in the management of hepatic encephalopathy and the potential role of rifaximin-α

2021

Objective Quality of life (QoL) is impaired in patients with hepatic encephalopathy and rifaximin-α can improve QoL within 6 months. This study assessed the importance of QoL as a therapeutic objective in hepatic encephalopathy management; whether QoL is routinely assessed in hepatic encephalopathy patients in clinical practice and the role of rifaximin-α in this context. Methods A survey was conducted of healthcare professionals (HCPs) from Europe and Australia involved in hepatic encephalopathy management. HCPs rated the importance of a range of therapeutic objectives on a 1–7 Likert scale (1 = not at all important; 7 = extremely important). HCPs were also required to provide three patien…

medicine.medical_specialtyhepatic encephalopathyrifaximin-αMEDLINEContext (language use)Rifaximinchemistry.chemical_compoundShort ArticleQuality of lifeInternal medicineHumanspatient record formMedicinesurveyIn patientHepatic encephalopathyHospital readmissionHepatologybusiness.industrycirrhosisGastroenterologymedicine.diseaseRifamycinsLactulosehumanitiesObjective qualitytherapeutic objectiveRifaximinEuropequality of lifechemistrybusinessEuropean Journal of Gastroenterology & Hepatology
researchProduct

28 Milrinone is Preferred to Levosimendan for Mesenteric Perfusion in Hypoxia-Reoxygenated Newborn Piglets on Dopamine

2010

28 Milrinone is Preferred to Levosimendan for Mesenteric Perfusion in Hypoxia-Reoxygenated Newborn Piglets on Dopamine

medicine.medical_specialtyintegumentary systembusiness.industryanimal diseasesLevosimendanHypoxia (medical)bacterial infections and mycosesfluids and secretionsDopamineInternal medicineAnesthesiaPediatrics Perinatology and Child HealthCardiologyMedicineMilrinonemedicine.symptombusinessPerfusionmedicine.drugPediatric Research
researchProduct

Predictors of visually induced motion sickness in women

2019

Abstract Background Visually induced motion sickness (VIMS) is commonly experienced when visual motion information is in conflict with motion information provided by the vestibular system and/or tactile and kinesthetic senses. According to some studies, women experience higher levels of VIMS than men, whereas other studies do not find this to be the case. Hypothesis This study investigated whether gender differences can be attributed to changes in VIMS-susceptibility due to the menstrual cycle and perceived menstrual pain. We hypothesized that higher perceived menstrual pain correlates positively with VIMS susceptibility. Methods We measured the influence of estimated concentrations of four…

medicine.medical_specialtymedia_common.quotation_subjectAudiologyStimulus (physiology)050105 experimental psychologyCorrelation03 medical and health sciences0302 clinical medicineMountainous terrainpolycyclic compoundsmedicine0501 psychology and cognitive sciencesElectrical and Electronic EngineeringMenstrual cyclemedia_commonVestibular systembusiness.industry05 social sciencesbiochemical phenomena metabolism and nutritionbacterial infections and mycosesmedicine.diseaseHuman-Computer InteractionMotion sicknessHardware and ArchitecturePostural stabilityFast motionbusiness030217 neurology & neurosurgeryDisplays
researchProduct

Mucormycosis of maxillary sinus in a newly diagnosed case of diabetes mellitus

2019

Rhinocerebral mucormycosis is the third most common fungal infection after aspergillosis and candidiasis. The importance of mucormycosis has grown in recent years, as the number of patients has increased dramatically. Herein, we present a case of a newly diagnosed patient of diabetes mellitus having ulcerated palate and destruction of maxillary sinus evident on computed tomography scan. A biopsy report was suggestive of mucormycosis. Aggressive medical and surgical treatment was done along with the treatment of diabetes mellitus.

medicine.medical_specialtymedicine.diagnostic_testMaxillary sinusbusiness.industryMucormycosisGeneral MedicineNewly diagnosedmedicine.diseaseAspergillosisSurgerymedicine.anatomical_structureDiabetes mellitusBiopsymedicineSurgical treatmentbusinessRhinocerebral mucormycosisJournal of Datta Meghe Institute of Medical Sciences University
researchProduct

Treatment of cervicofacial actinomycosis: a report of 19 cases and review of literature

2013

Objectives: Actinomycosis is a chronic suppurative granulomatous infection caused by the Actinomyces genus. Orocervicofacial actinomycosis is the most common form of the disease, seen in up to 55% of cases. All forms of actinomycosis are treated with high doses of intravenous penicillin G over two to six weeks, followed by oral penicillin V. Large studies on cervicofacial actinomycosis are lacking. Therefore proper guidelines for treatment and treatment duration are difficult to establish. The aim of this study is to establish effective treatment and treatment duration for orocervicofacial actinomycosis. Study design: A Pubmed and Embase search was performed with the focus on treatment and …

medicine.medical_specialtymedicine.drug_classAntibioticsOdontologíaActinomycosis CervicofacialSDG 3 - Good Health and Well-beingClavulanic acidmedicineHumansCombined Modality TherapyGeneral DentistryRetrospective StudiesOral Medicine and Pathologybusiness.industryRetrospective cohort studyAmoxicillin:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCombined Modality TherapyCiencias de la saludDermatologyAnti-Bacterial AgentsSurgeryPenicillinOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASEtiology/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingResearch-ArticleSurgeryActinomycosisbusinessmedicine.drugMedicina Oral, Patologia Oral y Cirugia Bucal
researchProduct

LAight® Therapy Significantly Enhances Treatment Efficacy of 16 Weeks of Topical Clindamycin Solution in Hurley I and II Hidradenitis Suppurativa: Re…

2021

<b><i>Background:</i></b> Hidradenitis suppurativa (HS) is a chronic, inflammatory, burdensome skin disease where medical first-line treatment is still limited to long-term, topical and/or systemic antibiotics. The RELIEVE study aimed at evaluating the efficacy of LAight® therapy – a combination of intense pulsed light and radiofrequency – as an adjunct treatment to first-line therapies in Hurley stage I and II HS. <b><i>Methods:</i></b> The RELIEVE study was performed as a two-period multicenter randomized controlled trial with blinded assessment. For period A from week 0 to week 16, the 88 participating subjects were randomized into either a…

medicine.medical_specialtymedicine.medical_treatmentDermatologyIntense pulsed lightSeverity of Illness Indexlaw.inventionRandomized controlled trialQuality of lifelawInternal medicineClinical endpointMedicineHumansHidradenitis suppurativabusiness.industryClindamycinClindamycinmedicine.diseaseTreatment efficacyAnti-Bacterial AgentsHidradenitis SuppurativaTreatment OutcomeTopical clindamycinChronic DiseaseQuality of Lifebusinessmedicine.drugDermatology (Basel, Switzerland)
researchProduct

One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy

2020

Background: Cataract surgery is the most common operation performed worldwide. A fixed topical corticosteroid-antibiotic combination is usually prescribed in clinical practice for 2 or more weeks to treat post surgical inflammation and prevent infection. However, this protracted schedule may increase the incidence of corticosteroid-related adverse events and notably promote antibiotic resistance. Methods: This International, multicentre, randomized, blinded-assessor, parallel-group clinical study evaluated the non-inferiority of 1-week levofloxacin/dexamethasone eye drops, followed by 1-week dexamethasone alone, vs. 2-week gold-standard tobramycin/dexamethasone (one drop QID for all schedul…

medicine.medical_specialtymedicine.medical_treatmentLevofloxacinArticleDexamethasoneCataract03 medical and health sciences0302 clinical medicineEndophthalmitisPharmacotherapyPostoperative ComplicationsLevofloxacinInternal medicinemedicineTobramycinClinical endpointHumansEndophthalmitis Cataract Intracameral cefuroximeAdverse effectDexamethasoneEndophthalmitisbusiness.industryCataract surgeryIntracameral cefuroximemedicine.diseasenot applicableAnti-Bacterial AgentsOphthalmologyItalySpain030221 ophthalmology & optometryOphthalmic Solutionsbusiness030217 neurology & neurosurgerymedicine.drug
researchProduct

Clarithromycin in the Management of Chronic Rhinosinusitis: Preliminary Results of a Possible Its New Use

2018

The aim of this study is to evaluate the efficacy and safety of prolonged therapy with low-dose clarithromycin in patients with chronic rhinosinusitis with polyps (CRSwP) after endoscopic sinus surgery (ESS). A total of 10 patients with CRSwP were identified and subjected to bilateral ESS. In post-operative patients they were treated with nasal wash with saline solution and steroid sprays (beclomethasone). During follow-up, after 30–40 days after the operation (M = 35.4 SD = +4.33), patients reported a worsening of symptoms with onset of nasal obstruction; reduction/loss of smell; headache; onset of viscous secretions and therefore all patients continued therapy with saline nasal irrigation…

medicine.medical_specialtymedicine.medical_treatmentMucous membrane of noseEosinophilGastroenterology03 medical and health sciences0302 clinical medicineHyposmiaEdemaInternal medicineClarithromycinClarithromycinmedicineChronic rhinosinusitis with polyp030223 otorhinolaryngologyTopical Steroid TherapySalineNosebusiness.industryOtorhinolaryngology2734 Pathology and Forensic MedicineChronic rhinosinusitis with polypsSurgerymedicine.anatomical_structureOtorhinolaryngologyOtorhinolaryngology030220 oncology & carcinogenesisOriginal ArticleSurgeryChronic rhinosinusitis with polyps; Clarithromycin; Eosinophilmedicine.symptombusinessmedicine.drug
researchProduct

Effects of sclerosing agents on head and neck hemangiomas : a systematic review

2019

Background The aim of this study was to systematically review the literature for studies that investigated the effects of sclerosing agents on head and neck hemangiomas. Material and methods Clinical trials, cohort studies, and descriptive studies were considered eligible and selected in a two-phase process. Six main electronic databases, in addition to three grey literature databases, were searched. Risk of bias (RoB) was assessed using the "Meta-Analysis of Statistics Assessment and Review Instrument" checklist. From fifty-six considered eligible, five were finally included. Results One article were judged at low, one at moderate, and three at high RoB. The sclerosing agents investigated …

medicine.medical_specialtymedicine.medical_treatmentReviewHemangioma030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemedicineSclerotherapyPingyangmycinAdverse effectGeneral DentistryPalsyOral Medicine and Pathologybusiness.industrySclerosing Solutions030206 dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseDermatologyClinical trialchemistryUNESCO::CIENCIAS MÉDICASbusinessCohort study
researchProduct